Atai Beckley, Inc. (ATAI)
7.39
+0.05
(+0.68%)
USD |
NASDAQ |
Sep 04, 16:00
7.32
-0.07
(-0.95%)
After-Hours: 20:00
Atai Beckley Research and Development Expense (Quarterly) : 28.07M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.07M |
| March 31, 2026 | 17.41M |
| December 31, 2025 | 18.96M |
| September 30, 2025 | 14.59M |
| June 30, 2025 | 11.09M |
| March 31, 2025 | 10.87M |
| September 30, 2024 | 12.29M |
| June 30, 2024 | 12.52M |
| March 31, 2024 | 11.45M |
| December 31, 2023 | 14.06M |
| September 30, 2023 | 13.22M |
| June 30, 2023 | 15.40M |
| March 31, 2023 | 19.22M |
| Date | Value |
|---|---|
| December 31, 2022 | 21.82M |
| September 30, 2022 | 18.99M |
| June 30, 2022 | 17.93M |
| March 31, 2022 | 15.40M |
| December 31, 2021 | 12.95M |
| September 30, 2021 | 13.36M |
| June 30, 2021 | 23.99M |
| March 31, 2021 | 6.557M |
| December 31, 2020 | |
| September 30, 2020 | 3.058M |
| June 30, 2020 | 2.974M |
| March 31, 2020 | 2.144M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.819B |
| GH Research Plc | 12.40M |
| Johnson & Johnson | 3.603B |
| Merck & Co., Inc. | 9.229B |
| Zoetis, Inc. | 173.00M |